- Pseudoephedrine 60mg / Acrivastine 8mg capsules
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Pseudoephedrine 60mg / Acrivastine 8mg capsules | Start Date 10-11-2002 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Name Basis
- Other
Codes
- ATC Code
- R01BA52
BNF | Start Date | End Date |
---|---|---|
Current BNF 03040100 | Start Date 04-04-2022 | End Date |
Previous BNF 03090200 | Start Date 02-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
42195511000001109 | 25-08-2023 | |
377470000 | 16-08-2005 | 24-08-2023 |
3462511000001107 | 10-11-2002 | 15-08-2005 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Acrivastine | Based on Ingredient Substance | 8 mg | ||
Pseudoephedrine hydrochloride | Based on Ingredient Substance | 60 mg |
Name
Pseudoephedrine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
60
Strength and UOM (Dmr)
Name
Acrivastine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
8
Strength and UOM (Dmr)
Parent Products
-
VTMPseudoephedrine + Acrivastine
-
VMP(Current) Pseudoephedrine 60mg / Acrivastine 8...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
12 capsule | 409 | Part VIIIA Category C |
24 capsule |